Remotely Observed Methadone Evaluation II for Opioid Use Disorder
This study is looking at a new way to help people with Opioid Use Disorder (OUD) who are taking methadone. Currently, methadone often requires daily visits to a clinic. This study is testing a special app called Sonara, which uses video recording and a tamper-evident seal to allow you to take your methadone at home more often. Researchers want to see if using Sonara helps people stay in treatment longer and reduces opioid use, compared to the usual way of getting methadone. You might be able to join if you are 18-64 years old, willing to be in a randomized study, and can complete interviews. You cannot join if you are pregnant, involved in the criminal justice system, have serious mental health problems, or are being treated with bupuprenorphine. The study aims to enroll 100 participants, but its current status is unclear.
- Study design
- This is an interventional study comparing the Sonara app to usual methadone take-home practices. It is a randomized trial, meaning participants will be assigned by chance to one of the two groups. The study plans to enroll 100 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will follow participants for 24 weeks to measure how long they stay in treatment and how many take-home doses they receive.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Remotely Observed Methadone Evaluation II
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Retention24 weeks
Length of time the patient remains in treatment after study enrollment
- Take homes received over time24 weeks
The number of take home doses of methadone received at 4-, 12-, and 24-weeks following randomization